Zurich (Switzerland), May 5, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today ...

Read Our Expert Reports and Published Proceedings Explore PNAS, the Flagship Scientific Journal of NAS Explore PNAS Nexus, the Open Access Scientific Journal of NAS Access Transportation Research ...

Just a few weeks after conception, stem cells are already orchestrating the future structure of the human brain. A new ...

A new experimental AI tool could help the government deliver its goal of building 1.5 million new homes over the next Parliament. Currently in early testing, the AI tool could reduce the time ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people ... Department of Internal Medicine and a research professor of nutritional sciences ...

(CNN) — Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type ... Endocrinology & Diabetes in the Department of Internal Medicine and a ...

Johns Hopkins is seeking people who have a diagnosis of bipolar I disorder to participate in a research study. The purpose of this study is to create a database of information that allows researchers ...

The advance booking of tickets for Kesari Chapter 2 opened today (Wednesday ... grossing around Rs 12.67 lakhs with an earning of Rs 1.02 cr (with block seats) all across India ahead of its ...

It turns out to be a 1951 publication in the Journal of Biological Chemistry describing an assay to determine the amount of protein in a solution 1. That ... (AI), research software and ...

Around 10% of underground tunnel workers in Queensland could develop silicosis, our new study has found. Silicosis is a serious, incurable lung disease caused by inhaling small particles of silica ...